PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 218 results · Oncology  · Clear
🔒 Subscribers only
AUTH/3701/10/22
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Astellas complained about Janssen’s provision of a nurse support service for Erleada (apalutamide) in prostate cancer, offered as part of a package deal.Astellas alleged the service was an induce…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3680/8/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas
Astellas made a voluntary admission about undeclared transfers of value (ToVs) to healthcare organisations (HCOs) in 2019, 2020 and 2021 and to patient organisations (POs) in 2020 and 2021.The issu…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3459/1/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Napp
A UK health professional complained about an advertisement for a forthcoming promotional Invokana (canagliflozin) webcast hosted on Diabetes On The Net (ref UK-INV-2000106, January 2021).The webcas…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3469/2/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda
An anonymous UK oncologist complained about a Takeda UK-organised, CPD-accredited online meeting: “ASH 2020 Highlights” (21 January 2021).The complainant said the content was good but there was…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3458/1/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Napp
An anonymous, contactable UK health professional complained about Napp’s promotion of Invokana (canagliflozin).The material was an on-demand promotional video hosted on Diabetes On The Net: “CR…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3568/10/21
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche made a voluntary admission about a certified promotional leavepiece for Gazyvaro (obinutuzumab) (ref M-GB-00000509), described as intended for haematology specialist nurses.A chart on page 6 …
Clauses: 9.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3494/3/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
An anonymous, contactable complainant alleged a senior named Bristol-Myers Squibb (BMS) UK employee promoted Opdivo (nivolumab) and Yervoy (ipilimumab) on LinkedIn by ‘liking’ a post from a sen…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3528/6/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Advanced Accelerator Applications
An anonymous complainant (a doctor) received three email invitations in April 2021 (15, 22 and 27) from a third party promoting an online CPD activity about PSMA-targeted therapy for metastatic cas…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3583/11/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Instagram ‘awards’ story featuring Itulazax imagery
A contactable complainant (agency employee) complained about Instagram advertisements for Itulazax (Betula verrucosa) posted by a UK-based creative agency and said the public could view readable pr…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3569/10/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
A complainant (member of the public/media) alleged that Nerlynx (neratinib maleate) had been promoted to the public.The allegation related to an advertising/marketing agency using materials includi…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3570/10/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Stallergenes Greer
A health professional complained about a Stallergenes Greer corporate LinkedIn post which referenced a sublingual house dust mite allergen immunotherapy tablet and listed brand names used in differ…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3514/5/21
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca advisory board
An ex-employee complained about a post-ASH (Dec 2020) virtual meeting described in documents as a “scientific exchange/debrief”, alleging it was actually a promotional, off-licence advisory boa…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3561/9/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An ex-employee complained about (1) a senior AstraZeneca employee’s LinkedIn post and (2) a Sunday Times article based on an AstraZeneca press release and an interview with a very senior employee…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3572/10/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A clinician (anonymous) complained that AstraZeneca employees (including senior UK cancer team members) shared LinkedIn posts linking to Blood Cancer UK, a third-party educational site.The complain…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3581/11/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A health professional complained that disease information aimed at patients/the public on the Roche UK website had not been certified as required for educational material. The complainant also al…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3579/11/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis employees’ LinkedIn ‘likes’ and comment on Glivec/Gleevec ruled misleading and public promo
An anonymous UK health professional complained about LinkedIn activity relating to imatinib (US brand Gleevec; UK brand Glivec).A US patient advocate posted about long-term survival after CML diagn…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3592/12/21
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Inter-company complaint by Bayer plc about a Janssen promotional on-demand video for Erleada (apalutamide) tablets: “Castration-resistant prostate cancer: The evidence supporting the benefits of …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3382/9/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Chugai
A UK health professional complained about a short YouTube video (dated 2014; uploaded 2015) that appeared to promote Granocyte (lenograstim), a prescription-only medicine.The complainant alleged it…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3394/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis disease awareness melanoma booklet
An anonymous, non-contactable complainant (described as a health professional) complained about a public-facing melanoma patient booklet on Novartis UK’s website: “Melanoma. Let’s get under t…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3408/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Amgen
An anonymous, non-contactable complainant (stating they were an Amgen employee) alleged the prescribing information (PI) on a Blincyto (blinatumomab) detail aid (ref UKIE-P-103-1115-117947(1)) was …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3399/10/20
HCP Hospitality & Meetings Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
Novartis voluntarily admitted that a representative failed to maintain high standards in discussions about Piqray (alpelisib) with two clinicians.In June 2020, the representative proactively held t…
Clauses: 27.2,27.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3372/8/20
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
A concerned UK health professional complained about a LinkedIn post by a US-based Bristol-Myers Squibb executive director that was ‘liked’ by a named UK employee (and later found to have been �…
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3434/12/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
A.Menarini
A concerned UK health professional complained about a Menarini Group LinkedIn post linking to a press release about SEL24/MEN1703 pharmacodynamic data from the DIAMOND-01 trial (ASH Annual Meeting …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3410/10/20
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Ipsen breached ABPI Code after employee’s LinkedIn job title referenced Cabometyx and RCC
A contactable complainant alleged an Ipsen employee advertised Cabometyx (cabozantinib) on LinkedIn, promoting a prescription only medicine (POM) to the public.The employee’s LinkedIn profile sho…
Clauses: 9.1,26.1
2020 🔒 Subscribe
← Prev 1 2 3 4 5 6 Next → Page 3 of 10 — 218 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews